Huize Holding Limited (NASDAQ: HUIZ) Secures MAS Licence in Singapore For Poni, Advancing its Dual-Hub Strategy

Stock Information for Titan Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Titan Pharmaceuticals Inc.

Huize Holding Limited to Hold Annual General Meeting on December 17, 2025
Huize Holding Limited Announces Resignation of an Independent Director
Huize Holding Limited Reports Second Quarter 2025 Unaudited Financial Results
Huize Holding Limited to Report Second Quarter 2025 Financial Results on September 12, 2025
Sidoti Events, LLC's Virtual August Micro-Cap Conference
Huize Holding Limited Reports First Quarter 2025 Unaudited Financial Results
Huize Holding Limited to Report First Quarter 2025 Financial Results on June 6, 2025
Huize Holding Limited Files 2024 Annual Report on Form 20-F

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.